novagraaf_logo
closeDichtbij
    • Merken en modellenmenu-bracket
      • Merken en modellen
          • Merkstrategie & beheermenu-bracket
            Portefeuillestrategie
          • Merkbeschikbaarheidsonderzoekmenu-bracket
            Screening & clearance
          • Merkregistratiemenu-bracket
            Merkbescherming
          • Bewaking en inbreukmenu-bracket
            Wereldwijde monitoring
          • Monitoring en handhavingmenu-bracket
            Online & offline
          • Vernieuwingen en registerwijzigingenmenu-bracket
            Verlengingen & wijzigingen
          • IE-consultancymenu-bracket
            Audits, licenties, M&A
          • MKB & Start-upsmenu-bracket
            Gerichte ondersteuning
    • Octrooienmenu-bracket
    • Domeinnamen →menu-bracket
    • Auteursrecht →menu-bracket
    • Oplossingenmenu-bracket
    • Experts →menu-bracket
    • Nieuws →menu-bracket
  • Merken en modellenmenu-bracket
    • Merken en modellen
        • Merkstrategie & beheermenu-bracket
          Portefeuillestrategie
        • Merkbeschikbaarheidsonderzoekmenu-bracket
          Screening & clearance
        • Merkregistratiemenu-bracket
          Merkbescherming
        • Bewaking en inbreukmenu-bracket
          Wereldwijde monitoring
        • Monitoring en handhavingmenu-bracket
          Online & offline
        • Vernieuwingen en registerwijzigingenmenu-bracket
          Verlengingen & wijzigingen
        • IE-consultancymenu-bracket
          Audits, licenties, M&A
        • MKB & Start-upsmenu-bracket
          Gerichte ondersteuning
  • Octrooienmenu-bracket
  • Domeinnamenmenu-bracket
  • Auteursrechtmenu-bracket
  • Oplossingenmenu-bracket
  • Expertsmenu-bracket
  • Nieuwsmenu-bracket
  • Contactmenu-bracket
Contactmenu-bracket
Meer
    • Over Novagraafmenu-bracket
      • Over Novagraaf
          • Over Novagraafmenu-bracket
            Uw strategische partner in IE
          • Missie & visiemenu-bracket
            Onze IE-experts en specialisten
          • Ons Managementteammenu-bracket
            Leiding en governance per land
          • Kantorenmenu-bracket
            Onze locaties in Europa
          • Geschiedenis en mijlpalenmenu-bracket
            Meer dan 135 jaar IE-ervaring
          • Maatschappelijke betrokkenheidmenu-bracket
            Onze maatschappelijke initiatieven
    • Carrièremenu-bracket
    • Log inmenu-bracket
    • Over Novagraafmenu-bracket
      • Over Novagraaf
          • Over Novagraafmenu-bracket
            Uw strategische partner in IE
          • Missie & visiemenu-bracket
            Onze IE-experts en specialisten
          • Ons Managementteammenu-bracket
            Leiding en governance per land
          • Kantorenmenu-bracket
            Onze locaties in Europa
          • Geschiedenis en mijlpalenmenu-bracket
            Meer dan 135 jaar IE-ervaring
          • Maatschappelijke betrokkenheidmenu-bracket
            Onze maatschappelijke initiatieven
    • Carrièremenu-bracket
    • Log inmenu-bracket
NL
Image for Nadège Lagneau

Nadège Lagneau

French and European Patent Attorney – Registered to practice before the USPTO
Genève
mail@novagraaf.ch
+41 (0)22 979 09 69

Genève

Nadège Lagneau, Ph.D. began her career in the United States in 1997 as a Research Fellow in Harvard Medical School and consequently pursued her research career in the R&D department of a Biotech in the Boston area in 1998, where she was Principal Scientist and responsible for the patent portfolio of the company.

Nadège specialised in Intellectual Property law after joining a renowned Boston Law Firm in 2001, where she rapidly qualified to practice in patent cases before the USPTO and acquired a solid experience in the patent practice of the United States Patent & Trademark Office (USPTO). After 6 years of IP practice in Boston, she joined the IP firm Bredema in 2007, followed by Novagraaf Technologies in the Paris area, as a result of the merger of the 2 firms in 2009. After 13 years of patent practice in the Paris offices of Novagraaf, she joined Novagraaf International SA in Geneva in September 2022. Before joining the Novagraaf Geneva office, she was Associate Head of the Chemistry & Life Sciences Department in France and was responsible for patent activities in the field of Chemistry.

Loopbaan

Nadège was a Harvard Medical School Post-doctoral Fellow, at the Center for Biochemical & Biophysical Sciences & Medicine (CBBSM), under the direction of Professor Bert L. Vallée (Edgar M. Bronfman Distinguished Senior Professor of Harvard Medical School). She holds a Ph.D. in Chemistry (Kansas State University, USA), a Master’s Degree in Chemistry (University of Caen, France) and a Chemical Engineering Degree in Materials and Fine Chemistry (Institut des Sciences of Matter and Radiation/ENSICAEN, France).

In 2008, Nadège graduated from the Center for International Intellectual Property Studies (C.E.I.P.I), patent law section (University of Strasbourg, France). She has been a European Patent Attorney since 2012 and a French Patent Attorney since 2016. Nadège has also been registered to practice before the USPTO since 2002.

Werkgebieden

Nadege is active notably in the fields of chemistry, materials science, nanotechnologies, polymers, chemistry of phospholipids, polypeptides, polysaccharides and biomolecules, composite materials, battery cells, electrode materials, filtration membranes, catalysts, nanocarbon materials, petrochemicals, adhesives, coating materials and treatment of surfaces, thin films, biomaterials and chemical compounds in agrochemistry, food industry, nutraceuticals, cosmetics, human and veterinary medicine/pharmaceuticals, and synthetic vectors in therapeutic and theranostic applications (nanoparticles, dendrimers, metal organic frameworks, zeolites).

Lidmaatschappen

Nadège is a member of the European Patent Institute (EPI) and the French Patent Attorneys Association, Compagnie Nationale des Conseils en Propriété Intellectuelle (CNCPI).

Expertisegebieden

  • Patent drafting and strategic management of patent prosecution worldwide
  • Opposition and appeal proceedings before the European Patent Office
  • Expert reports on patentability, freedom-to-operate, patent infringement and validity
  • National and international litigation and pre-litigation cases
  • Infringement seizures
  • IP strategies around innovative products
  • IP portfolio management and protection strategies


 

Vakgebieden

Levenswetenschappen & bio(medische) technologie
Cosmetica & persoonlijke verzorging
Octrooien
  • Europe excels in oncology startups but struggles to establish itself in cutting-edge cancer innovation
    Europe excels in oncology startups but struggles to establish itself in cutting-edge cancer innovation

    Europe excels in oncology startups but struggles to establish cutting-edge cancer innovation. Discover what the latest EPO data reveals about European oncology.
    Lees nu
  • Managing the priority disconnect between US and European patents
    Managing the priority disconnect between US and European patents

    Protecting patentable innovations in the US and EU is the foundation of many corporate patent portfolios. However, a first patent filing in the US can cause issues obtaining subsequent protection in E...
    Lees nu
  • Novagraaf

    Partner in IE-strategie, merkbescherming en handhaving.

    • Merken en modellen
      • Merkstrategie & beheer
      • Merkbeschikbaarheidsonderzoek
      • Merkregistratie
      • Bewaking en inbreuk
      • Monitoring en handhaving
      • Vernieuwingen en registerwijzigingen
      • IE-consultancy
      • MKB & Start-ups
    • Octrooien
      • Strategie & beheer
      • Octrooionderzoek
      • Aanvraag & procedures
      • Vernieuwingen
      • Wijzigingen
      • Octrooiadvies
    • Domeinnamen
    • Auteursrecht
    • Oplossingen
      • Online merkbescherming
      • EasyIP
      • End-to-end oplossingen
      • Wijn, bier & sterke dranken
      • EP-validatieportaal
      • Innovaties beheren
    • Experts
    • Nieuws
    Schrijf u in voor onze nieuwsbrief
    Ontvang belangrijke updates over IE en schrijf u in voor onze maandelijkse nieuwsbrief Perspectives.
    © 2026 Novagraaf. Alle rechten voorbehouden.
    Toestemmingsinstellingen
    • Legal notice and cookies policy
    • Privacy policy
    • Algemene voorwaarden